Thomas Norton

2.6k total citations
19 papers, 319 citations indexed

About

Thomas Norton is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, Thomas Norton has authored 19 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Virology and 4 papers in Infectious Diseases. Recurrent topics in Thomas Norton's work include HIV Research and Treatment (6 papers), Immunotherapy and Immune Responses (6 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Thomas Norton is often cited by papers focused on HIV Research and Treatment (6 papers), Immunotherapy and Immune Responses (6 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Thomas Norton collaborates with scholars based in United States and France. Thomas Norton's co-authors include Nathaniel R. Landau, Nina Bhardwaj, Elizabeth A. Miller, Adam Rupert, JoAnn M. Mican, Takuya Tada, Irini Sereti, Brian Porter, Nicolin Bloch and Jeff Skinner and has published in prestigious journals such as Blood, Journal of Virology and Scientific Reports.

In The Last Decade

Thomas Norton

19 papers receiving 315 citations

Peers

Thomas Norton
Kathleen Busman‐Sahay United States
Sen L Argentina
Laura Tarancón‐Díez Spain
Alessandra Fantauzzi Italy
Amrit Singh United States
Elizabeth Laidlaw United States
Camille E. Puronen United States
Christina Psomas France
J. F. Delfraissy France
Jess Maxwell United States
Kathleen Busman‐Sahay United States
Thomas Norton
Citations per year, relative to Thomas Norton Thomas Norton (= 1×) peers Kathleen Busman‐Sahay

Countries citing papers authored by Thomas Norton

Since Specialization
Citations

This map shows the geographic impact of Thomas Norton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Norton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Norton more than expected).

Fields of papers citing papers by Thomas Norton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Norton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Norton. The network helps show where Thomas Norton may publish in the future.

Co-authorship network of co-authors of Thomas Norton

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Norton. A scholar is included among the top collaborators of Thomas Norton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Norton. Thomas Norton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rofail, Diana, Selin Somersan-Karakaya, Yuming Zhao, et al.. (2024). Thematic analysis to explore patients’ experiences with long COVID-19: a conceptual model of symptoms and impacts on daily lives. BMJ Open. 14(1). e076992–e076992. 9 indexed citations
2.
Tada, Takuya, et al.. (2024). Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models. Journal for ImmunoTherapy of Cancer. 12(4). e008761–e008761. 1 indexed citations
3.
Rofail, Diana, Selin Somersan-Karakaya, Eleftherios Mylonakis, et al.. (2024). The symptoms evolution of long COVID‑19 (SE-LC19): a new patient-reported content valid instrument. Journal of Patient-Reported Outcomes. 8(1). 87–87. 2 indexed citations
4.
Hooper, Andrea T., Diana Rofail, Kusha Mohammadi, et al.. (2023). Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles. Scientific Reports. 13(1). 12784–12784. 3 indexed citations
5.
6.
Nagashima, Kirsten, Kaitlyn Gayvert, Chandrashekhar K. Korgaonkar, et al.. (2022). Evaluation of Common Gamma Chain Cytokine Signaling Blockade with REGN7257, an Interleukin 2 Receptor Gamma (IL2RG) Monoclonal Antibody, on Immune Cell Populations in Monkey and Human. Blood. 140(Supplement 1). 2924–2925. 1 indexed citations
7.
8.
Nagashima, Kirsten, Olivier Herbin, Dharani K. Ajithdoss, et al.. (2022). Blockade of Common Gamma Chain Cytokine Signaling with REGN7257, an Interleukin 2 Receptor Gamma (IL2RG) Monoclonal Antibody, Protected Mice from Inflammatory and Autoimmune Diseases. Blood. 140(Supplement 1). 473–474. 1 indexed citations
9.
Norton, Thomas, et al.. (2020). Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection. Molecular Therapy. 28(8). 1795–1805. 7 indexed citations
10.
Norton, Thomas, Anjie Zhen, Takuya Tada, et al.. (2019). Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice. Molecular Therapy. 27(5). 960–973. 28 indexed citations
11.
Badruddoja, Michael, Abhay Sanan, Kurt Schroeder, et al.. (2017). Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma. Cancer Chemotherapy and Pharmacology. 80(4). 715–721. 23 indexed citations
12.
Norton, Thomas & Elizabeth A. Miller. (2016). Recent Advances in Lentiviral Vaccines for HIV-1 Infection. Frontiers in Immunology. 7. 243–243. 11 indexed citations
13.
King, Patricia A., et al.. (2015). Role of patient treatment beliefs and provider characteristics in establishing patient-provider relationships. Family Practice. 32(2). 224–231. 20 indexed citations
14.
Norton, Thomas, Elizabeth A. Miller, Nina Bhardwaj, & Nathaniel R. Landau. (2015). Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro. Gene Therapy. 22(3). 227–236. 23 indexed citations
15.
Miller, Elizabeth A., Thomas Norton, Meagan P. O’Brien, et al.. (2014). Attenuated Listeria monocytogenes Vectors Overcome Suppressive Plasma Factors During HIV Infection to Stimulate Myeloid Dendritic Cells to Promote Adaptive Immunity and Reactivation of Latent Virus. AIDS Research and Human Retroviruses. 31(1). 127–136. 10 indexed citations
16.
Norton, Thomas, et al.. (2014). Orthopedic surgical site infections: analysis of causative bacteria and implications for antibiotic stewardship.. PubMed. 43(5). E89–92. 35 indexed citations
17.
Bloch, Nicolin, et al.. (2013). HIV Type 1 Infection of Plasmacytoid and Myeloid Dendritic Cells Is Restricted by High Levels of SAMHD1 and Cannot be Counteracted by Vpx. AIDS Research and Human Retroviruses. 30(2). 195–203. 39 indexed citations
18.
Hofmann, Henning, et al.. (2013). Inhibition of CUL4A Neddylation Causes a Reversible Block to SAMHD1-Mediated Restriction of HIV-1. Journal of Virology. 87(21). 11741–11750. 34 indexed citations
19.
Musselwhite, Laura W., Virginia Sheikh, Thomas Norton, et al.. (2011). Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV. AIDS. 25(6). 787–795. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen Busman‐Sahay Breakdown of academic impact, for papers by Sen L Breakdown of academic impact, for papers by Laura Tarancón‐Díez Breakdown of academic impact, for papers by Alessandra Fantauzzi Breakdown of academic impact, for papers by Amrit Singh Breakdown of academic impact, for papers by Elizabeth Laidlaw Breakdown of academic impact, for papers by Camille E. Puronen Breakdown of academic impact, for papers by Christina Psomas Breakdown of academic impact, for papers by J. F. Delfraissy Breakdown of academic impact, for papers by Jess Maxwell
Rankless by CCL
2026